CAPTRUST Financial Advisors’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Hold |
29,255
| – | – | ﹤0.01% | 2478 |
|
|
2025
Q1 | $19.2K | Hold |
29,255
| – | – | ﹤0.01% | 2321 |
|
|
2024
Q4 | $29.8K | Buy |
+29,255
| New | +$29.8K | ﹤0.01% | 2263 |
|
|
2022
Q3 | – | Sell |
-1,238
| Closed | -$5K | – | 3709 |
|
|
2022
Q2 | $5K | Sell |
1,238
-693
| -36% | -$2.8K | ﹤0.01% | 4116 |
|
|
2022
Q1 | $11K | Sell |
1,931
-77
| -4% | -$439 | ﹤0.01% | 3753 |
|
|
2021
Q4 | $15K | Buy |
2,008
+239
| +14% | +$1.79K | ﹤0.01% | 3486 |
|
|
2021
Q3 | $16K | Hold |
1,769
| – | – | ﹤0.01% | 3320 |
|
|
2021
Q2 | $21K | Sell |
1,769
-3,131
| -64% | -$37.2K | ﹤0.01% | 3079 |
|
|
2021
Q1 | $61K | Buy |
4,900
+1,173
| +31% | +$14.6K | ﹤0.01% | 2301 |
|
|
2020
Q4 | $58K | Sell |
3,727
-1,252
| -25% | -$19.5K | ﹤0.01% | 1762 |
|
|
2020
Q3 | $47K | Buy |
4,979
+128
| +3% | +$1.21K | ﹤0.01% | 1658 |
|
|
2020
Q2 | $46K | Buy |
+4,851
| New | +$46K | ﹤0.01% | 1653 |
|